Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: A preclinical study

British Journal of Cancer

Volumn 88, Issue 11, 2003, Pages 1780-1784

  Ludicke F ^a   Gabrecht, T ^b   Lange, N ^b   Wagnieres G ^b   Van Den Bergh, H ^b   Berclaz, L ^a   Major, A L ^a,c  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b EPFL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Ovarian cancer; Photodynamic diagnosis

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; GLASS FIBER; LEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLUE LIGHT; CANCER DIAGNOSIS; CANCER GRAFT; CANCER MODEL; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; FLUORESCENCE; IMMUNOCOMPETENCE; INTERMETHOD COMPARISON; LAPAROSCOPY; METASTASIS; NONHUMAN; OVARY CARCINOMA; PERITONEAL CAVITY; PERITONEUM METASTASIS; PHOTODYNAMICS; PHOTOSENSITIZATION; PRIORITY JOURNAL; RAT; RAT STRAIN; SPECTROFLUOROMETRY; WHITE LIGHT;

AMINOLEVULINIC ACID; ANIMALS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EPITHELIUM; FEASIBILITY STUDIES; FEMALE; FLUORESCENCE; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PHOTOSENSITIZING AGENTS; PROGNOSIS; PROTOPORPHYRINS; RATS; RATS, INBRED F344; SENSITIVITY AND SPECIFICITY;

EID: 0037928505     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600958     Document Type: Article

References (29)

1. Bagley Jr CM, Young RC, Schein PS, Chabner BA, DeVita VT (1973) Ovarian carcinoma metastatic to the diaphragm-frequently undiagnosed at laparotomy. A preliminary report. Am J Obstet Gynecol 116: 397-400
2. Buchsbaum HJ, Brady MF, Delgado G, Miller A, Hoskins WJ, Manetta A, Sutton G (1989) Surgical staging of carcinoma of the ovaries. Surg Gynecol Obstet 169: 226-232
3. Gahlen J, Pietschmann M, Prosst RL, Herfarth C (2001) Systemic vs local administration of delta-aminolevulinic acid for laparoscopic fluorescence diagnosis of malignant intra-abdominal tumors. Experimental study. Surg Endosc 15: 196-199
4. Gahlen J, Prosst RL, Pietschmann M, Haase T, Rheinwald M, Skopp G, Stern J, Herfarth C (2002) Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies. Ann Surg 235: 252-260
5. Helewa ME, Krepart GV, Lotocki R (1986) Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol 154: 282-286
6. Heyerdahl H, Wang I, Liu DL, Berg R, Andersson-Engels S, Peng Q, Moan J, Svanberg S, Svanberg K (1997) Pharmacokinetic studies on 5-aminole-vulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues. Cancer Lett 112: 225-231
7. Hornung R, Major AL, McHale M, Liaw LH, Sabiniano LA, Tromberg BJ, Berns MW, Tadir Y (1998) In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model. J Am Assoc Gynecol Laparosc 5: 141-148
8. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagnieres G, Zimmer G, Guillou L, Schmidlln F, Graber P, van den Bergh H, Leisinger HJ (1997a) Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 20: 402-408
9. Jichlinski P, Wagnieres G, Forrer M, Mizeret J, Guillou L, Oswald M, Schmidlln F, Graber P, van den BH, Leisinger HJ (1997b) Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer. Urol Res 25(Suppl 1): S3-S6
10. Kloek J, Akkermans W, Beijersbergen van Henegouwen GM (1998) Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 67: 150-154
11. Kriegmair M, Zaak D, Knuechel R, Baumgartner R, Hofstetter A (1999) Photodynamic cystoscopy for detection of bladder tumors. Semin Laparosc Surg 6: 100-103
12. Lange N, Jichlinski P, Zellweger M, Forrer M, Marti A, Guillou L, Kucera P, Wagnieres G, van den Bergh H (1999) Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 80: 185-193
13. Lange N, Vaucher L, Marti A, Etter AL, Gerber P, van den Bergh H, Jichlinski P, Kucera P (2001) Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia. J Biomed Opt 6: 151-159
14. Leblanc E, Querleu D, Narducci F, Chauvet MP, Chevalier A, Lesoin A, Vennin P, Taieb S (2000) Surgical staging of early invasive epithelial ovarian tumors. Semin Surg Oncol 19: 36-41
15. Major AL, Ludicke F, Campana A (2002a) Feasibility study to detect ovarian cancer micrometastases by fluorescence photodetection. Lasers Med Sci 17: 2-5
16. Major AL, Rose GS, Chapman CF, Hiserodt JC, Tromberg BJ, Krasieva TB, Tadir Y, Haller U, Di Saia PJ, Berns MW (1997) In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA). Gynecol Oncol 66: 122-132
17. Major AL, Rose GS, Svaasand LO, Ludicke F, Campana A, van Gemert MJ (2002b) Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: a toxicity study. J Photochem Photobiol B 66: 107-114
18. Marti A, Lange N, van den BH, Sedmera D, Jichlinski P, Kucera P (1999) Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol 162: 546-552
19. Monnier Ph, Savary M, Fontolliet C, Wagnières G, Châtelain A, Cornaz P, Depeursinge Ch, van den Bergh H (1990) Photodetection and photodynamic therapy of 'early' squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Lasers Med Sci 5: 149-169
20. Orenstein A, Kostenich G, Malik Z (1997) The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors. Cancer Lett 120: 229-234
21. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79: 2282-2308
22. Piver MS (1982) Optimal surgical therapy in stage I and II ovarian malignancies. Int J Radiat Oncol Biol Phys 8: 247-249
23. Rose GS, Tocco LM, Granger GA, DiSaia PJ, Hamilton TC, Santin AD, Hiserodt JC (1996) Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol 175: 593-599
24. Soper JT, Johnson P, Johnson V, Berchuck A, Clarke-Pearson DL (1992) Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet Gynecol 80: 949-953
25. Trimbos JB, Schueler JA, van der BM, Hermans J, van Lent M, Heintz AP, Fleuren GJ (1991) Watch and wait after careful surgical treatment and staging in well- differentiated early ovarian cancer. Cancer 67: 597-602
26. Wagnieres GA, Star WM, Wilson BC (1998) In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol 68: 603-632
27. Webber J, Kessel D, Fromm D (1997) Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid. J Photochem Photobiol B 37: 151-153
28. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer 77: 1-10
29. Young RC, Decker DG, Wharton JT, Piver MS, Sindelar WF, Edwards BK, Smith JP (1983) Staging laparotomy in early ovarian cancer. JAMA 250: 3072-3076